Membership Professional Bodies

    • Association of Physicians of India (API)
    • Indian Society of Oncology (ISO)
    • Indian Society of Medical and Paediatric Oncology (ISMPO)
    • European Society of Medical Oncology. (ESMO)
    • Indian Cooperative Oncology Network (ICON)
    • American Society of Clinical Oncology (ASCO)

Teaching Experience

S. No.UnitApptFromToTeaching Experience
1AFMC  PuneClinical Tutor (Med)Dec 1984Feb 19872 Years 2 Months
2MDTC, CH(SC) PuneClSpl (Med &Onco)Mar 1993Oct 19974 years 7 months
3CH(EC) KolkataOct 1997Apr 20002 years 5 months
4INHS Asvini, MumbaiApr 2000Feb 20021 years 1 months
Delhi UniversityProfessor of MedicineJuly 2002 to Jan 2006
5National Board of Examinations, Ansari Nagar, New DelhiProfessor of Medical OncologyDec 2002 till date
6Army Hospital R & R doFeb 200231 Jan 20063 years 11 months
7Rajiv Gandhi Cancer Institute and research centredoFeb 2006Oct 20093 years 8 months
8Artemis Health InstitutedoNov 2009April 20111 year and 5 months
9BLK Super speciality HospitalDoApril 2011Nov 20143 years and 7 months
10Max Super Speciality Hospital, Shalimar BaghDoNov


Dec 20195 years

Examiner ship experience: –

1DNB examination theory and/or practicalExaminer2018, 2014, 2004 and 2005
2DM (Medical Oncology) of Dr M G R Medical University, Chennai.Examiner


  1. Assessment of toxicity profile of chemotherapy in Indian geriatric patient population and utility of CRASH (chemotherapy risk assessment scale for high age patients) score”
  2. To evaluate the incident of skeletal related events(SRE)in metastatic bone disease and their co-relation with baseline bone density and vitamin D levels in a tertiary care cancer centre.
  3. Incidence of Neuropathy with weekly Paclitaxel and role of oral Glutamine Supplementation for prevention of Paclitaxel induced peripheral neuropathy.
  4. Clinical profile and response of chemotherapeutic agents in recurrent epithelial ovarian cancer: A retrospective in tertiary Cancer Institute.
  5. A prospective case control study to detect the association of Human papilloma virus and oropharyngeal cancer in a tertiary care level oncology centre in North India.
  6. To assess the efficacy of Targeted Therapy along with Chemotherapy in Recurrent and metastatic Head and neck cancer.
  7. A prospective study of quality of life and toxicity in patients of breast cancer on dose dense regimen.


Conferences organised/co-organised: (main ones)

  1. ONCOLOGY CME : AHRR : 2003 (Org Secy)
  2. RGICON : 2009 (Org Secy)
  3. ASK 10 : 2010. (Org Secy)
  4. INDIAN CANCER CONGRESS (1st) : 2013 (Chairperson Scientific Committee)
  5. ONCOCON 2017 (Chair )
  6. SABCS : 2018 (Chair)


National Level:

  • Attended and participated in more than 200 local, regional and national conferences in various cities in India.

International Level:

  • Attended several international conferences in oncology abroad (ASCO, ECCO, ESMO and others)


  1. Association of Physicians of India (API)
  2. Indian Society of Oncology (ISO)
  3. Indian Society of Medical and Paediatric Oncology (ISMPO)
  4. European Society of Medical Oncology. (ESMO)
  5. Indian Cooperative Oncology Network (ICON)
  6. American Society of Clinical Oncology (ASCO)